Q3 2023 · 13F-HR
Opaleye Management Inc.holdings as filed
Filed 2023-11-15 · accession 0001493152-23-041364
$307.4M
Reported value
40
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 415858109 | HROW | HARROW HEALTH INC | $54.5M | 17.7% | 3,795,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $42.2M | 13.7% | 4,146,138 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $20.3M | 6.61% | 6,468,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $15.8M | 5.14% | 1,890,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $15.0M | 4.87% | 653,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $14.1M | 4.58% | 1,205,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $11.5M | 3.74% | 360,400 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $11.4M | 3.71% | 439,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $11.0M | 3.58% | 370,000 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $10.1M | 3.30% | 2,430,270 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $8.4M | 2.73% | 311,500 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $8.1M | 2.64% | 1,209,380 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $6.0M | 1.95% | 750,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.0M | 1.63% | 875,405 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $4.8M | 1.57% | 500,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $4.7M | 1.53% | 584,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $4.6M | 1.49% | 90,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $4.5M | 1.46% | 2,692,594 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $4.5M | 1.46% | 320,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.1M | 1.32% | 1,915,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $4.0M | 1.29% | 4,754,200 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS INC | $3.9M | 1.28% | 308,500 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP DEL | $3.9M | 1.26% | 274,500 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.7M | 1.21% | 1,705,900 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.6M | 1.18% | 570,700 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $3.4M | 1.09% | 848,500 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $3.1M | 1.01% | 441,896 | Common | SOLE |
| 38341PAA0 | GOSS 5 06/01/27 | GOSSAMER BIO INC | $3.1M | 1.01% | 8,000,000 | Common | SOLE |
| 09075X108 | — | BRIDGEBIO PHARMA INC | $3.0M | 0.99% | 455,573 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $2.8M | 0.90% | 610,000 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS | $2.2M | 0.72% | 893,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIIENCES INC | $2.2M | 0.71% | 261,000 | Common | SOLE |
| 192005106 | CDXS | CODEXIS INC | $2.1M | 0.69% | 1,118,900 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $1.7M | 0.56% | 211,400 | Common | SOLE |
| 74017N105 | PGEN | PRECIGEN INC | $1.3M | 0.43% | 928,500 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $848,082 | 0.28% | 4,764,508 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $725,400 | 0.24% | 390,000 | Common | SOLE |
| 34960Q109 | — | FORTRESS BIOTECH INC | $580,600 | 0.19% | 2,000,000 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $505,750 | 0.16% | 425,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $90,000 | 0.03% | 30,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.